© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Association for International Arbitration and Upcoming Events
Legal
01/05/2015Association for International Arbitration and Upcoming Events

The Association for International Arbitration (AIA) is a non-profit organization open to all those interested in Alternative Dispute Resolution (ADR), irrespective of nationality and level of experience.

Read Full PostRead - Eye Icon
Indonesia’s Most Credible Intellectual Property Firm
Strategy
05/12/2016Indonesia’s Most Credible Intellectual Property Firm

Am Badar & Partners is one of the leading Intellectual Property Firms in Indonesia that handles all areas of IP and related IP matters.

Read Full PostRead - Eye Icon
Non-Harmonious Ends to Congruous Beginnings
Leadership
27/07/2015Non-Harmonious Ends to Congruous Beginnings

As parties enter into mergers, acquisitions, joint ventures or any sort of corporate deal, there is often an overriding sense of harmony that this is a win-win scenario. However, perceived wisdom is that the success of any M&A activity can in fact be a double

Read Full PostRead - Eye Icon
Wellington Equestrian Partners to Acquire International Polo Club and Surrounding Properties
Leadership
18/03/2016Wellington Equestrian Partners to Acquire International Polo Club and Surrounding Properties

Mark Bellissimo, CEO of Wellington Equestrian Partners (WEP), announced today that he has signed a definitive agreement to acquire Wellington's world renowned International Polo Club (IPC).

Read Full PostRead - Eye Icon
Shining The Light On A Medical Marvel
Innovation
18/12/2019Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-b

Read Full PostRead - Eye Icon
Best In-House Global Tax Adviser – Singapore
Finance
08/06/2016Best In-House Global Tax Adviser – Singapore

NOL is the largest container shipping company listed on the Singapore Exchange (SGX). With more than 7,000 employees and offices located in over 40 countries, the Group delivers quality services through its core business, APL.

Read Full PostRead - Eye Icon
Is Bitcoins a Good Investment? 4 Ways to Make Serious Money in Online Trading
Finance
15/11/2021Is Bitcoins a Good Investment? 4 Ways to Make Serious Money in Online Trading

Many people have asked the question: is Bitcoin a good investment? This is a simple question to answer, as Bitcoin has become the talk of town. This virtual currency is not governed by any government and it functions through the network of computers across the

Read Full PostRead - Eye Icon
Best Facility Management Group 2026
Finance
31/03/2026Best Facility Management Group 2026

Today, the multifaceted facilities management (FM) landscape consists of so many different elements that councils and companies are crying out for a service provider to cover all the bases under one roof.

Read Full PostRead - Eye Icon
WatchDog Wonder Wins Award
Innovation
19/03/2020WatchDog Wonder Wins Award

The importance of surveillance has grown significantly in the last few years as a sure-fire way of protecting people and property from harm. For over a decade, the team at WatchDog have played a major part in the maturing of the industry, standing at the foref



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow